article thumbnail

Doctors Perform First-Ever Human Bladder Transplant in U.S.

Drugs.com

MONDAY, May 19, 2025 Doctors in Southern California have performed the first human bladder transplant, offering new hope to people with serious bladder problems.The surgery was done earlier this month by two doctors from the University of C.

article thumbnail

Lilly gets FDA OK of modified dosing for Alzheimer’s drug

BioPharma Drive: Drug Pricing

A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to prescribe Lilly’s amyloid-busting drug.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO

BioPharma Drive: Drug Pricing

Doctors also wrestled with how best to use new bispecific antibodies, and expressed concern about looming cuts to science funding. Breast cancer study results impressed at this year’s meeting, but raised new questions.

article thumbnail

Why More Data Hasn’t Improved Clinical Trial Enrollment

H1 Blog

As Katz noted, “You have to find the doctor that meets this perfect identity painting of a patient, which is very difficult to do.” Knowing where a doctor works, not that hard. “Knowing where a doctor works, not that hard.

article thumbnail

Case Study: Two Examples of Successful Automation Integration at Altasciences for Pharmacokinetic Studies

Alta Sciences

After completing his doctorate, he moved into the industry by joining a startup that specialized in enzymatic DNA synthesis, where he enhanced their processes and reagents using automated liquid handling technology. About the Author Martin Rougée joined Altasciences in early 2024 as an Optimization Scientist.

article thumbnail

Q&A: One scientist’s bold vision to make on-demand treatments routine for life-threatening rare genetic diseases

Broad Institute

While doctors are cautious about using the word "cure" so early, it is a triumph for K.J.'s Doctors took donor T cells and performed three precise base edits on them, engineering them to attack leukemia cells while leaving healthy cells alone. s blood ammonia levels have dropped to the high end of normal for an infant.

article thumbnail

Genomic score predicts patients' progression to multiple myeloma

Broad Institute

Treating risk as simply high or low fails to capture the complexity of tumor timing and evolution, and we saw an opportunity to redefine it through whole-genome sequencing, said Alberge.

DNA